ArticleNeoplasia (New York, N.Y.)2026

Tumor-specific super-enhancer drives overexpression of EVI1/MECOM in ovarian cancer.

Sabrina Kruse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.